ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

WIL Wilmington Plc

408.00
8.00 (2.00%)
04 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Wilmington Plc LSE:WIL London Ordinary Share GB0009692319 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  8.00 2.00% 408.00 391.00 408.00 396.00 396.00 396.00 868,720 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Information Retrieval Svcs 126M 41.21M 0.4601 8.69 358.29M

Wilmington PLC UK Healthcare Business sold for £26.3 million

27/06/2024 7:00am

RNS Regulatory News


RNS Number : 0551U
Wilmington PLC
27 June 2024
 

27 June 2024

 

Wilmington plc

 

UK Healthcare Business sold for £26.3 million

 

Wilmington plc (LSE: WIL, "Wilmington" or the "Group"), the provider of data, information, education and training in the global Governance, Risk and Compliance markets, has sold its UK Healthcare Business for up to £26.3 million to Inspirit Franklin Holdings Ltd, an entity ultimately owned by funds managed by Inspirit Capital.

 

This transaction completes Wilmington's sale of its European healthcare businesses, following the disposal of the Group's French healthcare business, APM, announced on 26 April 2024 for €26 million. The total consideration across the two transactions is up to approximately £48.5 million.

 

The initial consideration of approximately £21.3 million comprises approximately £4.8 million in cash with the balance satisfied through the issue by the purchaser of secured loan notes.

 

The total consideration will increase by up to approximately £5.1 million, subject to the UK Healthcare Business achieving certain EBITDA targets for the financial year ending 30 June 2025 and will be satisfied by the issue of additional loan notes. The loan notes will be for a term of four years (subject to customary early redemption events) and will carry a variable interest rate equal to the Bank of England base rate.

 

The UK Healthcare Business includes the entire issued share capitals of Wilmington Healthcare Limited and Interactive Medica SL.

 

For the year ended 30 June 2023, the UK Healthcare Business had gross assets of £34.1 million and reported a profit before tax of £2.5 million.

 

The net proceeds of the disposal will be used for the general corporate purposes of the Group.

 

Mark Milner, Chief Executive Officer of Wilmington, said:

 

"The disposal of our UK Healthcare Business completes our divestment of our European healthcare businesses, at a combined multiple of 10 times FY23 EBITDA.

 

"I would like to thank the teams at APM and UK Healthcare for their hard work over their time at Wilmington and wish them and their new business owners the best for the future.

 

"The Group is now a high margin, pure-play platform, focusing on Governance, Risk and Compliance ("GRC"), providing intelligence, data, and training directly to customers who themselves operate in regulated markets. We continue to strengthen the Group by seeking high quality GRC assets that demonstrate our required characteristics."

 

For further information, contact:

  

Wilmington plc  

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

020 7490 0049

 

 

 

07990 858548

 

 

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISEAFKKAAALEAA

1 Year Wilmington Chart

1 Year Wilmington Chart

1 Month Wilmington Chart

1 Month Wilmington Chart